SCHEMBL6883751

SCHEMBL6883751

Cc1ccc2[nH]c(N3CCN(C)CC3)nc2c1

nearest known ligand 0.76

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.76
RAB9A P51151 1/20 0.76
HRH4 Q9H3N8 7/20 0.51
HTR3A P46098 4/20 0.49
KDM4E B2RXH2 2/20 0.49
TP53 P04637 1/20 0.49
HTR3E A5X5Y0 1/20 0.48
HTR3B O95264 1/20 0.48
HTR3D Q70Z44 1/20 0.48
HTR3C Q8WXA8 1/20 0.48
ALDH1A1 P00352 2/20 0.46
NPSR1 Q6W5P4 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23010600 0.85 HTR3A (0.63) NPC1RAB9AHTR3ATP53BCHE
SCHEMBL6236251 0.84 NPC1 (0.58) NPC1RAB9AHRH4HTR3AKDM4E
SCHEMBL6884875 0.84 NPC1 (0.58) NPC1RAB9AHRH4HTR3AKDM4E
SCHEMBL19145306 0.84 TP53 (0.64) NPC1RAB9AHTR3AKDM4ETP53
SCHEMBL28001120 0.82 TRPC3 (0.68) NPC1RAB9AHTR3ATP53TSHR
SCHEMBL5309716 0.80 BCHE (0.71) NPC1RAB9AHRH4HTR3ATP53
SCHEMBL19145516 0.75 NPC1 (0.46) NPC1RAB9AHRH4HTR3AKDM4E
SCHEMBL14046591 0.75 NPC1 (0.74) NPC1RAB9AHRH4HTR3ATP53
SCHEMBL25809621 0.75 BCHE (0.72) NPC1RAB9AHRH4HTR3ATP53
SCHEMBL14046593 0.75 NPC1 (0.70) NPC1RAB9AHRH4HTR3ATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021030620-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS NUVATION BIO INC. (US) 2021-02-18 WO disclosed
WO-2011084371-A1 AMINOBENZOQUINAZOLINONE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME CORP. (US) 2011-07-14 WO disclosed